Skip to Main Content

Paper Details

The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors.
Am J Cancer Res
3
2019
Author NameAffiliation
Daniel M BerneyBarts Cancer Institute, Queen Mary University of London London
Yong-Jie LuBarts Cancer Institute, Queen Mary University of London London
Yong-Jie LuAffiliated Wuxi No. 2 Hospital of Nanjing Medical University Wuxi
  • 1 - 3

Datasets

Release 1.2